Clinical Trial

Study of DM-101PX in Adults With Birch Pollen Allergy

Study acronym: BASIT
Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Randomized, double-blind placebo-controlled phase 2 trial with the aim to investigate safety and efficacy of DM-101-PX in reducing allergic symptoms provoked by nasal allergen challenge in birch pollen allergic adults. Expanded access to the study treatment is not available.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-11-20; most recent amendment 2026-04-27.
Status change: Recruiting → Active, Not Recruiting 2026-01-19
Trial Details
NCT Number NCT07254871
Lead Sponsor Desentum Oy
Conditions Birch Pollen Allergy
Enrollment 100 participants
Start Date 2025-09-26
Primary Completion 2026-04-15 (estimated)
Study Completion 2026-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-28